M6620
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for M6620, covering 2020-11-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]